ALPMY Stock Price, Chart, Stats & News
Astellas Pharma Inc. (ALPMY) is a dividend-paying stock with a current dividend yield of 3.11% as of Aug 14, 2026. It pays $0.4584 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a -7.53% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — ALPMY pays out about 35% of earnings.
ALPMY chart
About
Astellas Pharma Inc. operates as a global pharmaceutical enterprise, specializing in the research, development, manufacturing, and commercialization of a broad spectrum of medicinal products worldwide. The company's diverse pipeline and marketed portfolio address critical unmet medical needs across various therapeutic areas. In oncology, Astellas offers XTANDI, an androgen receptor signaling inhibitor used in prostate cancer; XOSPATA, a FLT3 inhibitor designed for adults with relapsed or refractory acute myeloid leukemia characterized by a FLT3 mutation; and PADCEV, a treatment option for patients with locally advanced or metastatic urothelial cancer.
Related lists
Similar securities
Based on sector and market capitalization
